FBK vs GILD · P/E 17, rev $454.8M vs P/E 18, rev $7.80B
FB Financial Corp (FBK) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
FB Financial Corp (FBK) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FBK revenue for 2026-06-30 was $454.8M. Net income was $116.2M. FBK currently screens at market cap $2.57B and trailing P/E 17.4.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FBK currently screens at market cap $2.57B and trailing P/E 17.4. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FBK and GILD stock pages for the full models.
Not investment advice.